NCT02176967 2025-12-22Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk NeuroblastomaChildren's Oncology GroupPhase 3 Active not recruiting621 enrolled
NCT01798004 2024-07-15Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk NeuroblastomaChildren's Oncology GroupPhase 1 Completed150 enrolled 9 charts